Gentamicin Sulfate

DRUG9 trials

Conditions

Epidermolysis BullosaHereditary Hypotrichosis SimplexInfectious endocarditis caused by Gram-positive cocci (staphylococciJunctional Epidermolysis BullosaNeurogenic BladderPelvic Organ ProlapsePneumoniaPostoperative Urinary Tract Infection

Phase 1

Gentamicin for RDEB

CompletedNCT03012191

University of Southern CaliforniaRecessive Dystrophic Epidermolysis Bullosa

Start: 2017-02-02End: 2018-08-31Updated: 2019-07-23

Gentamicin for Junctional Epidermolysis Bullosa

RecruitingNCT03526159

University of Southern CaliforniaJunctional Epidermolysis Bullosa

Start: 2018-06-01End: 2020-08-31Target: 6Updated: 2020-04-07

Topical Gentamicin Nonsense Suppression Therapy of EB

CompletedNCT04644627

Oslo University HospitalEpidermolysis Bullosa

Start: 2020-12-01End: 2022-05-01Updated: 2022-05-03

Phase 2

Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN

NCT03492866

Tel-Aviv Sourasky Medical CenterHereditary Hypotrichosis Simplex

Start: 2018-04-30End: 2019-04-30Target: 8Updated: 2018-04-10

Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury

CompletedNCT03503513

University of MichiganNeurogenic Bladder, Spinal Cord Diseases, Spinal Cord Injuries +1

Start: 2018-08-24End: 2023-09-30Updated: 2024-06-25

Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections

CompletedNCT03931408

University of LouisvilleNeurogenic Bladder, Spinal Cord Injuries

Start: 2019-02-19End: 2020-12-30Updated: 2025-01-29

Gentamicin Intravesical Efficacy for Infection of Urinary Tract

CompletedNCT04246996

Kaiser PermanentePelvic Organ Prolapse, Postoperative Urinary Tract Infection, Stress Urinary Incontinence

Start: 2020-01-29End: 2021-12-05Updated: 2022-11-08

Phase 3

A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia

CompletedNCT04041791

University of OxfordPneumonia

Start: 2019-08-19End: 2024-04-05Updated: 2024-07-08

Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci

Not yet recruitingCTIS2026-526149-91-00

Friedrich-Schiller-Universitaet Jenaenterococci, Infectious endocarditis caused by Gram-positive cocci (staphylococci, streptococci)

Target: 166Updated: 2026-06-30

Related Papers

A Pragmatic Trial of Antibiotics and Supportive Care for Severe Pneumonia in Hospitalized Children.

medRxiv2026-05-06

Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants